Seeking balance in the GM crop debate
نویسنده
چکیده
There’s a continuing gap between attitudes towards genetically modified (GM) crops in Europe and elsewhere. While the US, Canada, China, India and many other countries are adopting them with gusto, most European countries remain at best cautious and at worst completely hostile to their introduction. The reasons for Europe’s apparent Luddism are many and complex. In some countries there is a general abhorrence of any genetic manipulation. There is also a distrust of the food industry and official regulators, following numerous scares from salmonella, through Escherichia coli, to bovine spongiform encephalopathy (BSE or mad cow disease). Opponents argue that, although consumers may be taking risks by eating genetically modified food, all of the benefits go into the pockets of biotech companies. And there are genuine differences between farming practices in the US and Europe, where many farms are still relatively small and wildlife is dependent on particular farming techniques that critics fear will be changed by the new crops. Britain’s science academy, the Royal Society, held an open meeting last month to try to tackle these issues and present the scientific assessment of GM crops. To open, the meeting highlighted just how much change had resulted from increasingly intensive but conventional agriculture in Europe. For example, changes from spring to autumn-sown cereals has had a major impact on many species, especially birds. Eschewing ideological and theoretical arguments, the meeting focused on the practical issues surrounding the potential benefits and risks of GM crops. The vehemence of opposition to GM crops is surprising in the view of Europe’s willingness to embrace biotechnology for medical and other uses. There has, for example, been little ethical concern about the introduction of News focus
منابع مشابه
Genetically modified crops: methodology, benefits, regulation and public concerns.
The genetic modification of crop plants from the methodology involved in their production through to the current debate on their use in agriculture are reviewed. Techniques for plant transformation by Agrobacterium tumefaciens and particle bombardment, and for the selection of transgenic plants using marker genes are described. The benefits of currently available genetically modified (GM) crops...
متن کاملQuestions and Answers About Genetically Modified Crops: A Pocketful of Information Genetically Modified Crops– Take Part in the Dialogue Global agriculture finds itself engrossed in a heated debate over genetically modified (GM)
Global agriculture finds itself engrossed in a heated debate over genetically modified (GM) crops. This debate, which features science, economics, politics, and even religion, is taking place almost everywhere. It is going on in research labs, corporate boardrooms, legislative chambers, newspaper editorial offices, religious institutions, schools, supermarkets, coffee shops, and even in private...
متن کاملPrinciples of risk perception applied to gene technology.
As the intense debate about genetically modified (GM) crops and food in Europe and elsewhere shows, the public has become increasingly wary of new technologies that harbour possible risks. Probably even more important, they are not willing to accept some applications of these technologies without previous and thorough debate on their implications and potential hazards (Frewer, 2003). Although s...
متن کاملCommon interest
scientific and medical advice. That is what we are looking for from the work of this review group. " Barroso told EU leaders that food price rises had added " a new dimension " to the public debate about GM crops. He admitted people were worried about GM organisms in food and farming, but he said the EU was probably one of the biggest importers of GM feed as its livestock industry was highly de...
متن کاملStill the Great Debate – “Fair Balance” in Direct-to-Consumer Prescription Drug Advertising; Comment on “Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters”
The above titled paper examined the Food and Drug Administration’s (FDA’s) warning letters and notice of violations (NOV) over a 10-year period. Findings from this content analysis reinforced what has been the primary issue for prescription direct-to-consumer advertising (DTCA) since its beginning, the fair balance of risk and benefit information. As opposed to another analysis in 2026 about th...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Current Biology
دوره 13 شماره
صفحات -
تاریخ انتشار 2003